Xofigo

Xofigo (radium-223 dichloride) is a specialized medication used to treat advanced prostate cancer that has spread to the bones. It contains a radioactive substance that targets areas of broken or damaged bone caused by cancer. Once injected, it delivers localized radiation directly to these bone metastases, helping to slow disease progression and reduce pain. Because it selectively targets bone lesions, it minimizes damage to healthy tissue, improving quality of life and extending survival in suitable patients with advanced prostate cancer.